You are here: Industry Insights > X

News List

mRNA Beyond Vaccines: Expanding Applications in Pharma Nurah Ekhlaque
September 12, 2025
When most of us think of mRNA technology, COVID-19 vaccines instantly come to mind. But mRNA is not just a vaccine superstar, it’s an emerging powerhouse in pharmaceutical innovation.
Fishing Peptide Blockbusters from Hormones Exploring the Evolution and Future of Hormone-Based Therapeutic Peptides N55.6761
September 05, 2025
Hormone-derived peptides like semaglutide ($5.16B Q1 sales) redefine drug development through long-acting engineering. Their clinical success demonstrates the transformative potential of endogenous hormones as therapeutic blueprints.
Beyond Antibiotics: The Expanding Role of Anti-Infective APIs in Bacterial Infection Suzanne Elvidge
June 13, 2025
Beyond antibiotics??, novel anti-infective approaches include ??AMPs?? targeting biofilms, ??FMT capsules?? ,nanoparticle delivery systems??, and ??synbiotics?? to combat the global ??AMR crisis??.
Now and Next in Type 2 Diabetes Suzanne Elvidge
May 06, 2025
Type 2 diabetes, the most common form of diabetes, affects more than 800 million adults worldwide.
Pharmacovigilance Regulations and Application: Safeguarding Drug Safety in a Complex Global Environment David Orchard-Webb
May 06, 2025
In a pharmaceutical world characterized by rapid innovation and international marketplaces, safeguarding medication safety beyond commercialization has never been more important.
Another BlockBuster in HKEX18A Biotech Companies: IPO of DualityBio in Hong Kong, Introducing New Capital Engine in the ADC Field? Kevin
April 15, 2025
On April 15, DualityBio, a rising star in the ADC field, was officially listed on the HKEX, marking one of the most high-profile IPOs in recent years in Chapter 18A Biotech Companies.
The Role of Exosomes in Drug Delivery: A Natural Alternative to Synthetic Nanocarriers? Nurah Ekhlaque
April 09, 2025
Explore how exosome-based nanocarriers are shaping precision medicine by supporting targeted drug delivery in cancer and neurodegenerative diseases, with potential for reduced side effects.
Falling off the Patent Cliff: Patent Expirations in 2025 and Onwards Suzanne Elvidge
March 31, 2025
In the early 2010s, a new phenomenon hit the pharmaceutical industry – the patent cliff.
Improving the Patient Experience: Developing Patient-centric Dosage Forms Suzanne Elvidge
February 05, 2025
Medication non - adherence impacts many. Patient - centric drug design via simplifying dose, ease - of - taking, better packaging, and 3D - printing can boost adherence.
Which ADCs Are Favored by Global Companies in 2024? 2 Bispecific ADCs, 5 Transactions Exceeding USD 1 Billion Yi
January 23, 2025
ADCs are a hot drug R&D area, with 16 global approvals and a >$10B 2023 market. Chinese firms shine, 2 products approved, 11 out-licensing deals in 2024, 5 over $1B, boosting ADC internationalization.